Published in Malar J on March 16, 2012
Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013. Malar J (2014) 1.49
IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk. PLoS One (2012) 1.06
Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season. Malar J (2015) 0.97
Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Malar J (2013) 0.96
gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas. Parasit Vectors (2013) 0.92
Human antibody response to Anopheles saliva for comparing the efficacy of three malaria vector control methods in Balombo, Angola. PLoS One (2012) 0.88
Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker. PLoS One (2013) 0.87
Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal. Malar J (2013) 0.84
Assessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bites. Malar J (2012) 0.82
Anopheles gambiae salivary protein expression modulated by wild Plasmodium falciparum infection: highlighting of new antigenic peptides as candidates of An. gambiae bites. Parasit Vectors (2014) 0.80
Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites. Malar J (2015) 0.78
An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study. Parasit Vectors (2015) 0.76
Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities. PLoS One (2017) 0.76
Anopheline salivary protein genes and gene families: an evolutionary overview after the whole genome sequence of sixteen Anopheles species. BMC Genomics (2017) 0.75
Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area. PLoS Negl Trop Dis (2016) 0.75
Perceived malaria in the population of an urban setting: a skipped reality in Dakar, Senegal. Malar J (2012) 0.75
Operational Assessment of Long-Lasting Insecticidal Nets by Using an Anopheles Salivary Biomarker of Human-Vector Contact. Am J Trop Med Hyg (2016) 0.75
The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36
The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med (2008) 8.95
Malaria transmission in urban sub-Saharan Africa. Am J Trop Med Hyg (2003) 6.28
Urbanization in sub-saharan Africa and implication for malaria control. Am J Trop Med Hyg (2004) 5.07
Malaria on the move: human population movement and malaria transmission. Emerg Infect Dis (2000) 4.53
Vector density gradients and the epidemiology of urban malaria in Dakar, Senegal. Am J Trop Med Hyg (1992) 3.71
Blood-feeding arthropods: live syringes or invertebrate pharmacologists? Infect Agents Dis (1995) 2.81
Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, Tanzania. Malar J (2007) 2.57
Malaria and urbanization in sub-Saharan Africa. Malar J (2005) 2.56
Does irrigated urban agriculture influence the transmission of malaria in the city of Kumasi, Ghana? Acta Trop (2004) 2.25
Human immune response to sand fly salivary gland antigens: a useful epidemiological marker? Am J Trop Med Hyg (2000) 2.18
Human population, urban settlement patterns and their impact on Plasmodium falciparum malaria endemicity. Malar J (2008) 2.14
Rapid urban malaria appraisal (RUMA) in sub-Saharan Africa. Malar J (2005) 2.09
Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria. Trans R Soc Trop Med Hyg (2005) 1.90
Effects of ecological changes on the malaria vectors Anopheles funestus and the Anopheles gambiae complex of mosquitoes in Accra, Ghana. J Trop Med Hyg (1984) 1.85
A new tent trap for sampling exophagic and endophagic members of the Anopheles gambiae complex. Malar J (2009) 1.83
Comparative field evaluation of the Mbita trap, the Centers for Disease Control light trap, and the human landing catch for sampling of malaria vectors in western Kenya. Am J Trop Med Hyg (2004) 1.82
Sampling techniques for adult Afrotropical malaria vectors and their reliability in the estimation of entomological inoculation rate. Tanzan Health Res Bull (2005) 1.68
Highly focused anopheline breeding sites and malaria transmission in Dakar. Malar J (2009) 1.63
Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites. PLoS One (2008) 1.61
Natural human humoral response to salivary gland proteins of Anopheles mosquitoes in Thailand. Acta Trop (2006) 1.47
Malaria transmission in Dakar: a two-year survey. Malar J (2008) 1.38
An insight into the sialome of Anopheles funestus reveals an emerging pattern in anopheline salivary protein families. Insect Biochem Mol Biol (2006) 1.37
Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control. Am J Trop Med Hyg (2010) 1.31
Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Malar J (2009) 1.30
Urban agricultural land use and characterization of mosquito larval habitats in a medium-sized town of Côte d'Ivoire. J Vector Ecol (2006) 1.29
Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites. Malar J (2009) 1.25
Spatial heterogeneity and temporal evolution of malaria transmission risk in Dakar, Senegal, according to remotely sensed environmental data. Malar J (2010) 1.25
Human IgG antibody response to Glossina saliva: an epidemiologic marker of exposure to Glossina bites. Am J Trop Med Hyg (2008) 1.25
Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PLoS One (2010) 1.25
Anti-tick antibodies: an epidemiologic tool in Lyme disease research. Am J Epidemiol (1990) 1.23
Human IgG1 and IgG4: the main antibodies against Triatoma infestans (Hemiptera: Reduviidae) salivary gland proteins. Am J Trop Med Hyg (2001) 1.22
Anti-arthropod saliva antibodies among residents of a community at high risk for Lyme disease in California. Am J Trop Med Hyg (1999) 1.17
First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites. Trop Med Int Health (2010) 1.15
Seasonal increase in human IgE and IgG4 antisaliva antibodies to Aedes mosquito bites. Int Arch Allergy Immunol (1997) 1.14
IgE and IgG4 antibody responses to Aedes saliva in African children. Acta Trop (2007) 1.13
Conditions of malaria transmission in Dakar from 2007 to 2010. Malar J (2011) 1.08
Antihemostatic strategies of blood-feeding arthropods. Curr Drug Targets Cardiovasc Haematol Disord (2004) 1.08
[Malaria in the central health district of Dakar (Senegal). Entomological, parasitological and clinical data]. Sante (2000) 1.05
Using high spatial resolution remote sensing for risk mapping of malaria occurrence in the Nouna district, Burkina Faso. Glob Health Action (2009) 1.04
Mosquito saliva-specific IgE and IgG antibodies in 1059 blood donors. J Allergy Clin Immunol (2002) 0.95
Detection of mosquito saliva-specific IgE antibodies by capture ELISA. Allergy (1997) 0.91
[Biology of man-mosquito Plasmodium transmission]. Bull Soc Pathol Exot (2003) 0.90
Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis (2011) 7.42
Combination of malaria vector control interventions in pyrethroid resistance area in Benin: a cluster randomised controlled trial. Lancet Infect Dis (2012) 4.44
Prognostic value of thrombocytopenia in African children with falciparum malaria. Am J Trop Med Hyg (2002) 3.78
Protective efficacy of lambda-cyhalothrin treated nets in Anopheles gambiae pyrethroid resistance areas of Côte d'Ivoire. Am J Trop Med Hyg (2005) 2.89
Incidence of tick-borne relapsing fever in west Africa: longitudinal study. Lancet (2006) 2.77
Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J (2009) 2.76
Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J (2010) 2.75
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med (2007) 2.54
Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. Am J Trop Med Hyg (2006) 2.34
Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malar J (2004) 2.00
Combating malaria in Africa. Trends Parasitol (2002) 1.98
Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg (2006) 1.97
Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis (2010) 1.89
Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J Clin Microbiol (2006) 1.74
Highly focused anopheline breeding sites and malaria transmission in Dakar. Malar J (2009) 1.63
Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa. Microbes Infect (2007) 1.63
Vivax malaria in Mauritania includes infection of a Duffy-negative individual. Malar J (2011) 1.63
Malaria infection and disease in an area with pyrethroid-resistant vectors in southern Benin. Malar J (2010) 1.59
Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrob Agents Chemother (2009) 1.59
Social and environmental malaria risk factors in urban areas of Ouagadougou, Burkina Faso. Malar J (2009) 1.57
Childhood mortality and probable causes of death using verbal autopsy in Niakhar, Senegal, 1989-2000. Int J Epidemiol (2004) 1.56
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44
Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs. Malar J (2011) 1.40
Implication of haematophagous arthropod salivary proteins in host-vector interactions. Parasit Vectors (2011) 1.39
Malaria transmission in Dakar: a two-year survey. Malar J (2008) 1.38
An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. Am J Trop Med Hyg (2006) 1.35
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum. Antimicrob Agents Chemother (2007) 1.33
Changing malaria epidemiology and diagnostic criteria for Plasmodium falciparum clinical malaria. PLoS One (2012) 1.33
Comparative performances, under laboratory conditions, of seven pyrethroid insecticides used for impregnation of mosquito nets. Bull World Health Organ (2003) 1.33
Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control. Am J Trop Med Hyg (2010) 1.31
Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar J (2010) 1.31
Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline. Antimicrob Agents Chemother (2008) 1.29
Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis (2010) 1.27
Asymptomatic carriage of plasmodium in urban Dakar: the risk of malaria should not be underestimated. PLoS One (2012) 1.27
Impact of child malnutrition on the specific anti-Plasmodium falciparum antibody response. Malar J (2009) 1.25
Spatial heterogeneity and temporal evolution of malaria transmission risk in Dakar, Senegal, according to remotely sensed environmental data. Malar J (2010) 1.25
Malaria incidence in relation to rice cultivation in the irrigated Sahel of Mali. Acta Trop (2004) 1.25
Assessing key safety concerns of a Wolbachia-based strategy to control dengue transmission by Aedes mosquitoes. Mem Inst Oswaldo Cruz (2010) 1.25
Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PLoS One (2010) 1.25
Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors. PLoS One (2011) 1.24
Possible autochthonous malaria from Marseille to Minneapolis. Emerg Infect Dis (2007) 1.22
The use of remotely sensed environmental data in the study of malaria. Geospat Health (2011) 1.22
Genetic determination and linkage mapping of Plasmodium falciparum malaria related traits in Senegal. PLoS One (2008) 1.20
Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania. J Antimicrob Chemother (2011) 1.19
Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Malar J (2010) 1.19
Profile: the Ouagadougou Health and Demographic Surveillance System. Int J Epidemiol (2012) 1.18
Utilization of combined remote sensing techniques to detect environmental variables influencing malaria vector densities in rural West Africa. Int J Health Geogr (2012) 1.18
Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers. J Infect Dis (2010) 1.18
Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers. Am J Trop Med Hyg (2006) 1.13
Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg Infect Dis (2010) 1.11
A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malar J (2010) 1.11
Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother (2009) 1.10
Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum. Antimicrob Agents Chemother (2010) 1.10
In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs. Antimicrob Agents Chemother (2011) 1.10
Malaria prevalence and morbidity among children reporting at health facilities in Nouakchott, Mauritania. Trans R Soc Trop Med Hyg (2011) 1.10
Malaria transmission in Libreville: results of a one year survey. Malar J (2012) 1.10
Diagnostic criteria and risk factors for Plasmodium ovale malaria. J Infect Dis (2002) 1.10
Antimalarial drug use in general populations of tropical Africa. Malar J (2008) 1.09
Chloroquine resistance reversal agents as promising antimalarial drugs. Curr Drug Targets (2006) 1.09
Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl Trop Dis (2012) 1.08
Conditions of malaria transmission in Dakar from 2007 to 2010. Malar J (2011) 1.08
In vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti. Antimicrob Agents Chemother (2006) 1.08
Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal. Trans R Soc Trop Med Hyg (2008) 1.07
In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum. Antimicrob Agents Chemother (2008) 1.06
Malaria transmission and insecticide resistance of Anopheles gambiae in Libreville and Port-Gentil, Gabon. Malar J (2010) 1.06
Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J (2012) 1.06
Multiple independent introductions of Plasmodium falciparum in South America. Proc Natl Acad Sci U S A (2011) 1.06
Entomological and parasitological impacts of indoor residual spraying with DDT, alphacypermethrin and deltamethrin in the western foothill area of Madagascar. Malar J (2014) 1.05
Impact of long-lasting, insecticidal nets on anaemia and prevalence of Plasmodium falciparum among children under five years in areas with highly resistant malaria vectors. Malar J (2014) 1.05
Demonstration of a high level of parasite population homology by quantification of Plasmodium falciparum alleles in matched peripheral, placental, and umbilical cord blood samples. J Clin Microbiol (2005) 1.05
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum. Malar J (2010) 1.05
Using high spatial resolution remote sensing for risk mapping of malaria occurrence in the Nouna district, Burkina Faso. Glob Health Action (2009) 1.04
Health-seeking behaviour for childhood malaria: household dynamics in rural Senegal. J Biosoc Sci (2008) 1.04
Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal. Malar J (2009) 1.04
Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene. J Antimicrob Chemother (2010) 1.04
Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay. Malar J (2007) 1.02
Regression of severe tungiasis-associated morbidity after prevention of re-infestation: a case series from rural Madagascar. Am J Trop Med Hyg (2013) 1.01
The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens. Microbes Infect (2008) 1.01
Persisting mixed cryoglobulinemia in Chikungunya infection. PLoS Negl Trop Dis (2009) 1.00
Malaria transmission and insecticide resistance of Anopheles gambiae (Diptera: Culicidae) in the French military camp of Port-Bouët, Abidjan (Côte d'Ivoire): implications for vector control. J Med Entomol (2006) 1.00
Heritability of the human infectious reservoir of malaria parasites. PLoS One (2010) 1.00
The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance. ACS Chem Biol (2011) 0.99
Hidden Plasmodium falciparum parasites in human infections: different genotype distribution in the peripheral circulation and in the placenta. Infect Genet Evol (2002) 0.99